The National Institutes of Health (NIH) has announced a funding opportunity with the number RFA-CA-24-012, titled “Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional).” This discretionary grant, categorized under Cancer Detection and Diagnosis Research (CFDA Number: 93.394), aims to enhance existing NCI R01 research projects by integrating new technical approaches or instruments developed through the NCI Innovative Molecular Analysis Technologies (IMAT) program. With an award ceiling of $150,000, this grant is geared towards fostering advancements in cancer research through the adoption of innovative technologies.
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage revision applications from current NCI R01 research projects. These revisions are expected to expand upon the original research questions or significantly accelerate progress by incorporating emerging technologies from the NCI IMAT program. The NOFO emphasizes the importance of interdisciplinary collaboration in developing innovative tools and methods that not only enable in-depth cancer research but also accelerate scientific discovery. This initiative is a strategic move to incentivize independent validation and expedite the adoption of these emerging technologies by the appropriate research communities. The grant represents a critical investment in the fight against cancer, providing researchers with the resources to leverage cutting-edge technologies for deeper insights and more effective solutions in cancer detection, diagnosis, and treatment. This initiative reflects the NIH’s commitment to driving innovation and collaboration in cancer research, with the ultimate goal of improving patient outcomes and advancing the field of oncology.
Opportunity ID: 351178
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-24-012 |
| Funding Opportunity Title: | Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | |
| Expected Number of Awards: | |
| CFDA Number(s): | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 28, 2023 |
| Last Updated Date: | Nov 28, 2023 |
| Original Closing Date for Applications: | Oct 01, 2024 |
| Current Closing Date for Applications: | Oct 01, 2024 |
| Archive Date: | Nov 06, 2024 |
| Estimated Total Program Funding: | |
| Award Ceiling: | $150,000 |
| Award Floor: | $ |
Eligibility
| Eligible Applicants: | State governments Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education For profit organizations other than small businesses County governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI R01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this NOFO are meant to incentivize independent validation and accelerate the adoption of these emerging technologies by appropriate research communities. As a component of the NCI IMAT program, this NOFO aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-012.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact: NIH Grants Information
grantsinfo@nih.gov |